DAIC

JUNE 21, 2024

milla1cf Fri, 06/21/2024 - 20:10 June 21, 2024 — UC San Francisco interventional cardiologists and interventional echocardiographers recently performed the health system’s first commercial transcatheter tricuspid valve replacement procedure using the Edwards EVOQUE system. by the Food and Drug Administration.

Tricuspid 105

Tricuspid Quality of Life Open-Heart Surgery Interventional Cardiology 105

DAIC

FEBRUARY 2, 2024

Photo: Edwards Lifesciences milla1cf Fri, 02/02/2024 - 09:33 February 2, 2024 — Edwards Lifesciences Corporation announced the company’s EVOQUE tricuspid valve replacement system is the first transcatheter therapy to receive U.S. Food and Drug Administration (FDA) approval for the treatment of tricuspid regurgitation (TR).

Tricuspid 100

Tricuspid Quality of Life Bicuspid/Mitral Innovation 100

DAIC

FEBRUARY 15, 2024

Food and Drug Administration ( FDA ) confirmed 13 to 1, with 0 abstention that the benefits of Abbott's TriClip™ transcatheter edge-to-edge repair (TEER) system outweighed the risks for the treatment of people with tricuspid regurgitation (TR). On the final question of the benefit of TriClip versus the risk, the vote was 13 to 1 in favor.

Tricuspid 102

Tricuspid Heart Valves Quality of Life Bicuspid/Mitral 102

DAIC

APRIL 30, 2024

Tricuspid Valve Repair Existing literature on national surgical outcomes of isolated tricuspid valve repair or replacement is based on data from over a decade ago and may not reflect current practice results. Analysis of 13,587 patients undergoing isolated tricuspid valve surgery from 2017 to 2023 revealed a 5.5%

TAVR 111

TAVR Aortic valve Tricuspid Coronary Artery Bypass Graft 111

CardiacWire

DECEMBER 13, 2024

The new funding eclipses the $31M Series B round that Capstan raised in August 2023, bringing its total funding to over $150M. Currently, there are no commercially available catheter-based implants for completely replacing a leaky mitral or tricuspid valve, meaning the diseases are largely treated via open-heart surgery.

Open-Heart Surgery 52

Open-Heart Surgery Tricuspid Bicuspid/Mitral Aortic valve 52

Society of Thoracic Surgeons - Allied Health

NOVEMBER 15, 2022

Event 2023 STS Coding Workshop kchalko Tue, 11/15/2022 - 16:12 Event dates Feb 10–11, 2023 Location Virtual Registrants : To access the library of on-demand content, log into the STS Learning Center. Then go to “In Progress” courses on the dashboard or look in the “My Activities” tab. Missed the event? STS Members receive a discount!

Reimbursement 52

Reimbursement Cardiothoracic Document Congenital 52

DAIC

JUNE 27, 2024

led by Chairs Ed Nicol, MD, MBA, MSCCT, who served as SCCT President 2023-2024 term, and Maros Ferencik, MD, PhD, MCR, MSCCT, incoming 2024-2025 President. . - 5:00 p.m., a general session on “Cardiac CT in clinical trials” will be featured. The closing session on Sunday will run from 11:50 a.m. -

Congenital Heart Disease 105

Congenital Heart Disease Coronary Artery Disease Congenital Heart Disease 105